NCT05428748

Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers

An Open-label, Parallel and Randomized Trial to Assess the Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Liquid I.V. · Academic / Other
• Sex: All
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

This clinical trial design aims to evaluate the safety and tolerability of a novel hydration drink in health volunteers.

Conditions

• Tolerance

Interventions

Type	Name	Description
OTHER	1 serving of test product	Participants will consume 1 serving/day of the test product for 28 days
OTHER	2 servings of test product	Participants will consume 2 servings/day of the test product for 28 days
OTHER	3 servings of test product	Participants will consume 3 servings/day of the test product for 28 days
OTHER	Placebo	Participants will consume 1 serving/day of the placebo for 28 days

Timeline

• Start date: 2022-09-01
• Primary completion: 2023-02-01
• Completion: 2023-03-01
• First posted: 2022-06-23
• Last updated: 2024-07-29

Locations

1 site across 1 country: United States